Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $2.82 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• GMR Solutions to reprice $2.9B term loan, pay down $200M in debt